ArticleFrontiers in oncology2024

Clinical factors and major pathological response after neoadjuvant chemoimmunotherapy in potentially resectable lung squamous cell carcinoma.

Ye Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.